ReviewJournal of pharmacopuncture2026
Acupuncture and Moxibustion for Subthreshold Depression: a systematic review and Bayesian network meta-analysis.
Review in Journal of pharmacopuncture, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Subthreshold depression (SD), a precursor stage of depression, has gained considerable interest in recent years. Acupuncture and moxibustion have unique advantages in the treatment of depressive disorders. This systematic review and Bayesian network meta-analysis (NMA) aimed to evaluate the comparative effects of acupuncture and moxibustion therapies on SD and provide clinical recommendations. Methods: Eight databases were searched from their inception to January 1, 2026, for randomized controlled trials (RCTs) on acupuncture and moxibustion for SD. We included 17 studies with six different therapies. The primary and secondary outcomes were scores on the Hamilton Depression Rating Scale (HAMD) and the Center for Epidemiologic Studies Depression scale (CES-D), respectively. A random-effects Bayesian NMA was conducted using the gemtc package in R. Results: Acupuncture + moxibustion and acupuncture alone were associated with greater reductions in HAMD scores than placebo, no treatment, and Western medicine. In addition, acupuncture + moxibustion showed greater reductions in HAMD scores than acupoint herbal patching and psychological treatment. Acupuncture + moxibustion and moxibustion were associated with greater reductions in CES-D scores than placebo. Acupuncture + moxibustion and acupuncture alone resulted in greater score reductions than no treatment. Among the included therapies, acupuncture + moxibustion therapy was ranked highest in terms of surface under the cumulative ranking curve values for both HAMD (93.56%) and CES-D (96.21%). Conclusion: This Bayesian NMA suggests that acupuncture + moxibustion may have a relatively favorable ranking for improving SD symptoms, providing preliminary evidence to inform future clinical research and practice. However, the generalizability and evidence quality were limited by the single-center, small-sample design of most included studies. Further high-quality RCTs are warranted to validate these findings.Systematic review registration PROSPERO, CRD42023483384 (version 2.0).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.